Also, although our study focused on ACC and SCLC, our screening data revealed high DLK1 expression across several additional metastatic tumor types such as germ cell tumors and sarcomas and recent parallel work has demonstrated DLK1 as an immunotherapeutic cell surface target in pediatric neuroblastoma9. This evidence concerns the gene DLK1 and testicular germ cell tumor.